2-(5-Bromo­pyridin-3-yl)-5-[3-(4,5,6,7-tetra­hydro­thieno[3,2-c]pyridine-5-ylsulfon­yl)thio­phen-2-yl]-1,3,4-oxa­diazole

In the title compound, C(18)H(13)BrN(4)O(3)S(3), the tetra­hydro­pyridine ring adopts a half-chair conformation with the central methyl­ene-C atom of the NCH(2)CH(2) unit at the flap. The dihedral angles between the tetra­hydro­pyridine ring and the pyridine and two thio­phene rings are 69.34 (13) 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Fun, Hoong-Kun, Hemamalini, Madhukar, Rai, Sankappa, Isloor, A. M., Shetty, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2011
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201536/
https://www.ncbi.nlm.nih.gov/pubmed/22058804
http://dx.doi.org/10.1107/S1600536811038529
Descripción
Sumario:In the title compound, C(18)H(13)BrN(4)O(3)S(3), the tetra­hydro­pyridine ring adopts a half-chair conformation with the central methyl­ene-C atom of the NCH(2)CH(2) unit at the flap. The dihedral angles between the tetra­hydro­pyridine ring and the pyridine and two thio­phene rings are 69.34 (13) 5.66 (13) and 68.63 (13)°, respectively, while the dihedral angle between the 1,3,4-oxadiazole and tetra­hydro­pyridine rings is 54.76 (13)°. The mol­ecule is stabilized by an intra­molecular C—H⋯N inter­action. In the crystal, adjacent mol­ecules are connected via bifurcated C—H⋯(N,O) hydrogen bonds, forming a chain along the b axis.

Ejemplares similares